8-K Announcements
6Material company update
May 11, 2026·SEC
Material company update
Apr 22, 2026·SEC
Material company update
Mar 16, 2026·SEC
DocGo Inc.(DCGO)Earnings, Financials & Key Ratios
DCGO•NASDAQ
Price updated Jun 19, 2026
AboutDocGo, Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also offers mobile health services through its platform that are performed at home and offices; COVID-19 testing; and event services, which include on-site healthcare support at sporting events and concerts. DocGo, Inc. was incorporated in 2015 and is headquartered in New York, New York.Show more
- Revenue$322M-47.7%
- EBITDA-$73M-264.9%
- Net Income-$182M-1012.4%
- EPS (Diluted)-1.84-1122.2%
- Gross Margin30.65%-11.5%
- EBITDA Margin-22.81%-415.5%
- Operating Margin-27.67%-694.7%
- Net Margin-56.61%-1845.9%
- ROE-82.71%-1383.3%
DCGO Key Insights
DocGo Inc. (DCGO) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Strong 5Y sales CAGR of 27.9%
- ✓Share count reduced 9.5% through buybacks
- ✓Trading at only 0.4x book value
- ✓Efficient asset utilization: 1.5x turnover
✗Weaknesses
- ✗Profits declining 66.3% over 5 years
- ✗Weak momentum: RS Rating 14 (bottom 14%)
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when DCGO posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
DCGO Price & Volume
DocGo Inc. (DCGO) stock price & volume — 10-year historical chart
Loading chart...
DCGO Growth Metrics
DocGo Inc. (DCGO) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years27.91%
3 Years-9.9%
TTM-42.03%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-29208.66%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-16508.7%
Return on Capital
10 Years-6.6%
5 Years-1.17%
3 Years-7.74%
Last Year-36.89%
DCGO Recent Earnings
DocGo Inc. (DCGO) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 2/12 qtrs (17%)●Beat Revenue 10/12 qtrs (83%)
Q2 2026Latest
May 11, 2026Metric
Actual
Est
EPS
$0.12-500.0%
$0.02
Rev
$76M+4.2%
$72M
Q2 2026
Mar 16, 2026Metric
Actual
Est
EPS
$0.53-430.0%
$0.10
Rev
$75M+6.6%
$70M
Q4 2025
Nov 10, 2025Metric
Actual
Est
EPS
$0.11+26.2%
$0.15
Rev
$71M+0.6%
$70M
Q3 2025
Aug 7, 2025Metric
Actual
Est
EPS
$0.11-10.0%
$0.10
Rev
$80M+16.7%
$69M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 11, 2026 | $0.12vs $0.02-500.0% | $76Mvs $72M+4.2% |
| Q2 2026 | Mar 16, 2026 | $0.53vs $0.10-430.0% | $75Mvs $70M+6.6% |
| Q4 2025 | Nov 10, 2025 | $0.11vs $0.15+26.2% | $71Mvs $70M+0.6% |
| Q3 2025 | Aug 7, 2025 | $0.11vs $0.10-10.0% | $80Mvs $69M+16.7% |
Based on last 12 quarters of dataView full earnings history →
DCGO Peer Comparison
DocGo Inc. (DCGO) competitors in Home-based care services — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 OPRX | 93.45M | 4.98 | 18.44 | 18.78% | 6.37% | 5.47% | 0.20 | |
 TALK | 872.74M | 5.21 | 130.25 | 22% | 0.49% | 1.03% | ||
 HIMS | 7.79B | 35.47 | 69.55 | 59% | -0.56% | -2.48% | 2.34 | |
 DOCS | 3.83B | 20.46 | 20.88 | 13.05% | 30.4% | 19.36% | 0.01 | |
 AMR | 2.36B | 185.77 | -39.11 | -27.99% | -1.83% | -2.47% | 0.02 | |
 EVGO | 608.35M | 1.94 | -6.26 | 49.55% | -11.15% | -12.2% | 0.28 | |
 AMSF | 588.66M | 31.32 | 12.68 | 2.63% | 14.27% | 9.68% | 0.00 | |
 ALHC | 4.47B | 21.86 | -5908.11 | 46.06% | 0.47% | 11.5% | 1.89 |
Compare DCGO vs Peers
DocGo Inc. (DCGO) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
DCGO Income Statement
DocGo Inc. (DCGO) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 48.3M | 94.09M | 318.72M | 440.52M | 624.29M | 616.56M | 322.2M | 301.71M |
Revenue Growth % | - | 94.81% | 238.74% | 38.21% | 41.72% | -1.24% | -47.74% | -42.03% |
Cost of Goods Sold | 35.11M | 62.74M | 208.97M | 285.79M | 428.91M | 402.98M | 223.44M | 212.57M |
COGS % of Revenue | 72.69% | 66.68% | 65.57% | 64.88% | 68.7% | 65.36% | 69.35% | - |
Gross Profit | 13.19M▲ 0% | 31.35M▲ 137.7% | 109.75M▲ 250.1% | 154.72M▲ 41.0% | 195.38M▲ 26.3% | 213.57M▲ 9.3% | 98.76M▼ 53.8% | 89.15M▲ 0% |
Gross Margin % | 27.31% | 33.32% | 34.43% | 35.12% | 31.3% | 34.64% | 30.65% | 29.55% |
Gross Profit Growth % | - | 137.67% | 250.1% | 40.98% | 26.28% | 9.31% | -53.76% | - |
Operating Expenses | 33.95M | 46.1M | 94.39M | 132.89M | 180.33M | 184.89M | 187.91M | 199.76M |
OpEx % of Revenue | 70.3% | 49% | 29.62% | 30.17% | 28.89% | 29.99% | 58.32% | - |
Selling, General & Admin | 28.55M | 39.41M | 83.56M | 116.94M | 153.04M | 157.41M | 158.69M | 31.21T |
SG&A % of Revenue | 59.11% | 41.88% | 26.22% | 26.55% | 24.51% | 25.53% | 49.25% | - |
Research & Development | 1.22M | 1.19M | 3.32M | 5.38M | 10.86M | 11.59M | 13.56M | 13.63M |
R&D % of Revenue | 2.53% | 1.26% | 1.04% | 1.22% | 1.74% | 1.88% | 4.21% | - |
Other Operating Expenses | 4.18M | 5.51M | 7.51M | 10.57M | 16.43M | 15.88M | 15.66M | 2M |
Operating Income | -20.76M▲ 0% | -14.76M▲ 28.9% | 15.36M▲ 204.1% | 21.83M▲ 42.2% | 15.05M▼ 31.0% | 28.69M▲ 90.6% | -89.16M▼ 410.8% | -110.61M▲ 0% |
Operating Margin % | -42.99% | -15.68% | 4.82% | 4.96% | 2.41% | 4.65% | -27.67% | -36.66% |
Operating Income Growth % | - | 28.92% | 204.06% | 42.16% | -31.04% | 90.56% | -410.77% | - |
EBITDA | -16.58M | -9.25M | 22.87M | 32.4M | 31.49M | 44.57M | -73.5M | -96.06M |
EBITDA Margin % | -34.33% | -9.83% | 7.18% | 7.35% | 5.04% | 7.23% | -22.81% | -31.84% |
EBITDA Growth % | - | 44.21% | 347.23% | 41.66% | -2.81% | 41.56% | -264.89% | -772.73% |
D&A (Non-Cash Add-back) | 4.18M | 5.51M | 7.51M | 10.57M | 16.43M | 15.88M | 15.66M | 14.55M |
EBIT | -20.76M | -14.76M | 20.56M | 21.83M | 15.05M | 29.68M | -89.16M | -93.86M |
Net Interest Income | -545.87K | -204.63K | -763.03K | 762.68K | 1.68M | -1.93M | -1.01M | -687.56K |
Interest Income | 545.87K | 0 | 0 | 762.68K | 1.68M | 236.95K | 0 | 0 |
Interest Expense | 0 | 204.63K | 763.03K | 0 | 0 | 2.17M | 1.01M | 687.56K |
Other Income/Expense | -428.28K | 125.91K | 4.44M | 950.26K | 1.24M | -939.72K | -98.34M | -78.77M |
Pretax Income | -21.19M▲ 0% | -14.63M▲ 31.0% | 19.8M▲ 235.3% | 22.78M▲ 15.1% | 16.29M▼ 28.5% | 27.75M▲ 70.3% | -187.5M▼ 775.7% | -189.38M▲ 0% |
Pretax Margin % | -43.87% | -15.55% | 6.21% | 5.17% | 2.61% | 4.5% | -58.19% | -62.77% |
Income Tax | 47.03K | 167.44K | 615.7K | -7.96M | 6.24M | 14.39M | 8.87M | 12.61M |
Effective Tax Rate % | -0.22% | -1.14% | 3.11% | -34.95% | 38.33% | 51.85% | -4.73% | -6.66% |
Net Income | -20.21M▲ 0% | -14.36M▲ 28.9% | 23.74M▲ 265.3% | 34.58M▲ 45.7% | 6.86M▼ 80.2% | 19.99M▲ 191.5% | -182.4M▼ 1012.4% | -187.76M▲ 0% |
Net Margin % | -41.84% | -15.26% | 7.45% | 7.85% | 1.1% | 3.24% | -56.61% | -62.23% |
Net Income Growth % | - | 28.95% | 265.35% | 45.66% | -80.17% | 191.5% | -1012.36% | -29208.66% |
Net Income (Continuing) | -21.24M | -14.8M | 19.18M | 30.74M | 10.05M | 13.36M | -196.37M | -201.99M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 10.89M | 11.95M | 7.48M | 5.7M | 4.38M | -5.74M | -18.14M | -21.1M |
EPS (Diluted) | -0.20▲ 0% | -0.14▲ 30.0% | 0.25▲ 278.6% | 0.34▲ 36.0% | 0.06▼ 80.9% | 0.18▲ 177.3% | -1.84▼ 1122.2% | -1.90▲ 0% |
EPS Growth % | - | 30% | 278.57% | 36% | -80.91% | 177.35% | -1122.22% | -16508.7% |
EPS (Basic) | -0.20 | -0.14 | 0.30 | 0.34 | 0.07 | 0.20 | -1.84 | - |
Diluted Shares Outstanding | 100.22M | 100.22M | 94.86M | 102.98M | 105.62M | 109.42M | 99.07M | 98.75M |
Basic Shares Outstanding | 100.22M | 100.22M | 80.29M | 101.23M | 103.51M | 102.4M | 99.07M | 98.75M |
Dividend Payout Ratio | - | - | - | - | - | 6474653.57% | - | - |
DCGO Balance Sheet
DocGo Inc. (DCGO) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|
Total Current Assets | 59.14M | 58.42M | 256.03M | 271.08M | 338.87M | 304.49M | 152.4M | 138.17M |
Cash & Short-Term Investments | 47.74M | 32.42M | 175.54M | 157.34M | 59.29M | 89.24M | 51.02M | 35.68M |
Cash Only | 47.74M | 32.42M | 175.54M | 157.34M | 59.29M | 89.24M | 51.02M | 35.68M |
Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts Receivable | 10.16M | 24.85M | 78.38M | 103M | 262.08M | 210.9M | 92.89M | 93.97M |
Days Sales Outstanding | 76.8 | 96.42 | 89.77 | 85.34 | 153.23 | 124.85 | 105.23 | 126.01 |
Inventory | 0 | 0 | 0 | 4.48M | 0 | 0 | 0 | 0 |
Days Inventory Outstanding | - | - | - | 5.72 | - | - | - | - |
Other Current Assets | 0 | 0 | 0 | 6.27M | 17.5M | 4.34M | 3.7M | 3.25M |
Total Non-Current Assets | 41.82M | 41.75M | 53.57M | 122.2M | 151.58M | 151.13M | 64.7M | 71.06M |
Property, Plant & Equipment | 20.41M | 21.1M | 26.24M | 39.37M | 38.42M | 42.18M | 43.5M | 42.01M |
Fixed Asset Turnover | 2.37x | 4.46x | 12.15x | 11.19x | 16.25x | 14.62x | 7.41x | 6.95x |
Goodwill | 6.31M | 6.61M | 8.69M | 38.9M | 47.54M | 47.43M | 0 | 0 |
Intangible Assets | 9.97M | 10.67M | 10.68M | 22.97M | 37.68M | 25.73M | 0 | 644.13K |
Long-Term Investments | 0 | 0 | 589.06K | 597.98K | 553.57K | 5.55M | 0 | 35.17M |
Other Non-Current Assets | 5.13M | 3.36M | 7.38M | 10.4M | 15.5M | 21.83M | 20.67M | 3.34M |
Total Assets | 100.96M▲ 0% | 100.17M▼ 0.8% | 309.6M▲ 209.1% | 393.28M▲ 27.0% | 490.45M▲ 24.7% | 455.62M▼ 7.1% | 217.1M▼ 52.4% | 209.23M▲ 0% |
Asset Turnover | 0.48x | 0.94x | 1.03x | 1.12x | 1.27x | 1.35x | 1.48x | 1.02x |
Asset Growth % | - | -0.78% | 209.07% | 27.03% | 24.71% | -7.1% | -52.35% | -148.52% |
Total Current Liabilities | 9.73M | 23.5M | 57.88M | 100.16M | 170.12M | 121.81M | 67.49M | 77.22M |
Accounts Payable | 947.94K | 3.95M | 15.83M | 21.58M | 19.83M | 28.36M | 11.11M | 13.87M |
Days Payables Outstanding | 9.85 | 23 | 27.66 | 27.56 | 16.87 | 25.68 | 18.15 | 18.52 |
Short-Term Debt | 564.91K | 664.36K | 626.33K | 664.91K | 25.03M | 30.01M | 51.74K | 10.18M |
Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 680.49K | 3.58M | 11.89M | 49.38M | 39.81M | 27.4M | 23.91M | 24.46M |
Current Ratio | 6.08x | 2.49x | 4.42x | 2.71x | 1.99x | 2.50x | 2.26x | 1.79x |
Quick Ratio | 6.08x | 2.49x | 4.42x | 2.66x | 1.99x | 2.50x | 2.26x | 1.79x |
Cash Conversion Cycle | - | - | - | 63.5 | - | - | - | 107.48 |
Total Non-Current Liabilities | 11.87M | 9.73M | 24.67M | 14.19M | 15.16M | 18.64M | 23.74M | 20.8M |
Long-Term Debt | 751.5K | 594.49K | 1.3M | 1.24M | 41.59K | 5.21K | 183.84K | 171.71K |
Capital Lease Obligations | 11.12M | 9.14M | 9.85M | 12.96M | 15.12M | 18.63M | 18.78M | 76.66M |
Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 13.52M | 0 | 0 | 0 | 4.78M | 2.48M |
Total Liabilities | 21.6M | 33.23M | 82.55M | 114.35M | 185.28M | 140.44M | 91.23M | 98.02M |
Total Debt | 15.54M | 13.89M | 16.51M | 19.91M | 46.5M | 57.19M | 29.18M | 28.51M |
Net Debt | -32.2M | -18.53M | -159.03M | -137.42M | -12.79M | -32.05M | -21.84M | -7.17M |
Debt / Equity | 0.20x | 0.21x | 0.07x | 0.07x | 0.15x | 0.18x | 0.23x | 0.26x |
Debt / EBITDA | - | - | 0.72x | 0.61x | 1.48x | 1.28x | - | -0.30x |
Net Debt / EBITDA | - | - | -6.95x | -4.24x | -0.41x | -0.72x | - | 0.07x |
Interest Coverage | - | -72.12x | 26.94x | - | - | 13.70x | -87.92x | -136.52x |
Total Equity | 79.36M▲ 0% | 66.95M▼ 15.6% | 227.06M▲ 239.2% | 278.93M▲ 22.8% | 305.17M▲ 9.4% | 315.18M▲ 3.3% | 125.87M▼ 60.1% | 111.21M▲ 0% |
Equity Growth % | - | -15.64% | 239.16% | 22.84% | 9.41% | 3.28% | -60.06% | -152.52% |
Book Value per Share | 0.79 | 0.67 | 2.39 | 2.71 | 2.89 | 2.88 | 1.27 | 1.13 |
Total Shareholders' Equity | 68.47M | 55M | 219.58M | 273.23M | 300.79M | 320.92M | 144.01M | 132.31M |
Common Stock | 0 | 0 | 10.01K | 10.24K | 10.41K | 10.19K | 9.86K | 9.88K |
Retained Earnings | -72.94M | -87.3M | -63.56M | -28.97M | -21.39M | -1.4M | -183.8M | -198.56M |
Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accumulated OCI | -244.88K | -48.54K | -32.5K | 741.21K | 1.48M | 1.22M | 2.39M | 2.25M |
Minority Interest | 10.89M | 11.95M | 7.48M | 5.7M | 4.38M | -5.74M | -18.14M | -21.1M |
DCGO Cash Flow Statement
DocGo Inc. (DCGO) cash flow — operating, investing & free cash flow history
| Metric | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 | TTM |
|---|---|---|---|---|---|---|---|---|
Cash from Operations | -14.21M | -10.65M | -1.95M | 28.87M | -64.22M | 70.34M | 34.45M | -4.66T |
Operating CF Margin % | -29.41% | -11.32% | -0.61% | 6.55% | -10.29% | 11.41% | 10.69% | - |
Operating CF Growth % | - | 25% | 81.72% | 1582.47% | -322.45% | 209.52% | -51.02% | -48240485.85% |
Net Income | -21.24M | -14.8M | 19.18M | 30.74M | 6.86M | 19.99M | -196.37M | -187.76M |
Depreciation & Amortization | 4.18M | 5.51M | 7.07M | 10.57M | 16.43M | 15.88M | 15.66M | 11.9M |
Stock-Based Compensation | 457.47K | 687.07K | 1.38M | 8.05M | 20.97M | 13.63M | 17.44M | 12.61M |
Deferred Taxes | 2.47M | 1.85M | -630.38K | -9.96M | -1.98M | 3.47M | 7.75M | 11.67M |
Other Non-Cash Items | 147.51K | -300K | -142.67K | 2.64M | 6.62M | -2.16M | 108.31M | 12.04T |
Working Capital Changes | -224.22K | -3.61M | -28.8M | -13.18M | -113.12M | 19.52M | 81.66M | 68.86M |
Change in Receivables | -2.28M | -16.15M | -58M | -8.42M | -160.52M | 41.27M | 112.5M | 78.26M |
Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Change in Payables | -100.67K | 3.01M | 11.88M | 3.64M | -1.78M | 8.56M | -17.64M | -7.26M |
Cash from Investing | -2.97M | -6.04M | -8.59M | -38.45M | -29.88M | -10.87M | -39.08M | 1.66T |
Capital Expenditures | -1.45M | -4.36M | -4.81M | -3.2M | -7.58M | -3.83M | -4.54M | -3.08M |
CapEx % of Revenue | 3% | 4.64% | 1.51% | 0.73% | 1.21% | 0.62% | 1.41% | 1.02% |
Acquisitions | -335.48K | 1.78M | -1.96M | -32.95M | -19.46M | -310.45K | -16.4M | -12.75M |
Investments | - | - | - | - | - | - | - | - |
Other Investing | -1.19M | -3.45M | -1.82M | -2.3M | -2.84M | -1.73M | -31.3M | 1.66T |
Cash from Financing | 56.34M | -812.09K | 155.21M | -6.18M | 1.12M | -24.15M | -50.82M | -2.46T |
Debt Issued (Net) | -3.2M | -2.28M | -2.82M | -3.94M | 20.7M | 613.55K | -35.17M | -35.29M |
Equity Issued (Net) | 49.04M | 0 | 177.62M | -3.73M | 1.58M | -13.76M | -10.83M | -5.08M |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | -1.29T | 0 | 0 |
Share Repurchases | 0 | 0 | -479.33K | -3.73M | 0 | -13.76M | -10.83M | -5.08M |
Other Financing | 10.5M | 1.47M | -19.6M | 1.49M | -21.17M | 1.29T | -4.82M | -2.46T |
Net Change in Cash | 38.91M▲ 0% | -17.31M▼ 144.5% | 144.65M▲ 935.6% | -15M▼ 110.4% | -91.89M▼ 512.7% | 35.12M▲ 138.2% | -54.85M▼ 256.2% | -5.67T▲ 0% |
Free Cash Flow | -18.01M▲ 0% | -16.97M▲ 5.8% | -8.6M▲ 49.3% | 23.37M▲ 371.6% | -74.35M▼ 418.1% | 64.5M▲ 186.8% | 27.02M▼ 58.1% | -5.09T▲ 0% |
FCF Margin % | -37.29% | -18.04% | -2.7% | 5.31% | -11.91% | 10.46% | 8.39% | -1686400.73% |
FCF Growth % | - | 5.76% | 49.3% | 371.61% | -418.11% | 186.76% | -58.11% | -6032961.84% |
FCF per Share | -0.18 | -0.17 | -0.09 | 0.23 | -0.70 | 0.59 | 0.27 | -51527.12 |
FCF Conversion (FCF/Net Income) | 0.70x | 0.74x | -0.08x | 0.83x | -9.36x | 3.52x | -0.19x | 27099.31x |
Interest Paid | 1.07M | 1.05M | 840.75K | 756.6K | 850.34K | 2.91M | 2.67M | 1.89M |
Taxes Paid | 47.03K | 117.44K | 615.7K | 1.51M | 4.25M | 7.25M | 0 | 4.74M |
DCGO Key Ratios
DocGo Inc. (DCGO) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | -19.63% | 16.15% | 13.67% | 2.35% | 6.45% | -82.71% | -95.61% |
Return on Invested Capital (ROIC) | -23.16% | 19.78% | 15.63% | 5.2% | 7.48% | -34.54% | -49.61% |
Gross Margin | 33.32% | 34.43% | 35.12% | 31.3% | 34.64% | 30.65% | 29.55% |
Net Margin | -15.26% | 7.45% | 7.85% | 1.1% | 3.24% | -56.61% | -62.23% |
Debt / Equity | 0.21x | 0.07x | 0.07x | 0.15x | 0.18x | 0.23x | 0.26x |
Interest Coverage | -72.12x | 26.94x | - | - | 13.70x | -87.92x | -136.52x |
FCF Conversion | 0.74x | -0.08x | 0.83x | -9.36x | 3.52x | -0.19x | 27099.31x |
Revenue Growth | 94.81% | 238.74% | 38.21% | 41.72% | -1.24% | -47.74% | -42.03% |
Related:DCGO Dividend History·DCGO Revenue History·DCGO Price History·DCGO P/E History·DCGO Financial Ratios·DCGO Institutional Holders
DCGO SEC Filings & Documents
DocGo Inc. (DCGO) SEC filings — annual & quarterly reports (10-K, 10-Q)
DCGO Frequently Asked Questions
DocGo Inc. (DCGO) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
DocGo Inc. (DCGO) reported $301.7M in revenue for fiscal year 2025. This represents a 525% increase from $48.3M in 2019.
DocGo Inc. (DCGO) saw revenue decline by 47.7% over the past year.
DocGo Inc. (DCGO) reported a net loss of $187.8M for fiscal year 2025.
Dividend & Returns
DocGo Inc. (DCGO) has a return on equity (ROE) of -82.7%. Negative ROE indicates the company is unprofitable.
DocGo Inc. (DCGO) had negative free cash flow of $5.09T in fiscal year 2025, likely due to heavy capital investments.